Phase 3 Readout~month
Phase 3 Topline: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a G
- Company
- Oscar Health Inc. (OSCR)
- Indication
- Glioblastoma
Other upcoming events for OSCR
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.